Skip to main content
January 21, 2025
Question

Issue with html text in email body

  • January 21, 2025
  • 5 replies
  • 0 views

While sending the email, some of the text is getting removed and receiving only partial text.

Below is the html text:

<p><span style="font-size: 10pt;">Dear colleagues,</span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" 0in;padding:0in;mso-ansi-language:en-us'="" style="font-size: 10pt;">&nbsp;</span></span><span style="font-size:10.0pt;"></span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" '="" style="">Please note that the EU approval by CHMP Positive opinion has been granted on 05 December 2024 for&nbsp;</span><span style="">KEYTRUDA (pembrolizumab) for variation EMEA/H/C/3820/II/016 which removes the instruction "Remove from light" for the diluted product from the Product information</span></span><span style="">.</span></p><p style="text-align:start;"><span style=""><span>&nbsp;</span></span></p><p style="text-align:start;"><span style=""><span style="">There is no corresponding CCDS update for this update,however the correction is linked to CCDS-MK3475-IV-042024.</span></span></p><p style="text-align:start;"><span style=""><span>&nbsp;</span></span></p><p style="text-align:start;"><span style="font-size: 10pt;">This variation has an impact on Section 6.3 of the KEYTRUDA SPC, as well as the information for healthcare professionals in the Leaflet.</span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" 0in;padding:0in;mso-ansi-language:en-us'="">Priority level is: Standard</span>.</span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" 0in;padding:0in;mso-ansi-language:en-us'="">&nbsp;</span></span><span style="font-size:10.0pt;"></span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" 0in;padding:0in;mso-ansi-language:en-us'="">Please note that, due to approval of procedures II/0160 +II/0161 + II/0162 in the same time frame, there are only consolidated PI’s with the changes of the 3 procedures available in MUSE -</span></span> <span style="">muse.merck.com</.../p><p style="text-align:start;"><span style=""><span>&nbsp;</span></span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" 0in;padding:0in;mso-ansi-language:en-us'="">Therefore, we attach the English WRM and CRT PI with the changes of II/0162 only to this mail.</span></span><span></span></p><p style="text-align:start;"><span style=""><span>&nbsp;</span></span></p><p style="text-align:start;"><span style=""><span windowtext="" 1.0pt;mso-border-alt:none="" 0in;padding:0in;mso-ansi-language:en-us'="">Thank you and warm regards,</span></span></p><p style="text-align:start;"><span style=""><span style="font-size:10.0pt;">Natalia</span></span></p><p></p>

Below is the email received:

In the email after "Dear colleagues" it  directly shows "Priority level -"  instead it should show

Help me in resolving this issue with html text.

    5 replies

    mpoojas0001
    January 30, 2025

    Hi [mention:a5732d26eb3840a7b63ef0bcb4455329:e9ed411860ed4f2ba0265705b8793d05] , Here is the corrected version

    <p style="font-size: 10pt;">Dear colleagues,</p>

    <p style="font-size: 10pt;">Please note that the EU approval by CHMP Positive opinion has been granted on 05 December 2024 for
    KEYTRUDA (pembrolizumab) for variation EMEA/H/C/3820/II/016, which removes the instruction "Remove from light" for the diluted product from the Product Information.</p>

    <p style="font-size: 10pt;">There is no corresponding CCDS update for this update; however, the correction is linked to CCDS-MK3475-IV-042024.</p>

    <p style="font-size: 10pt;">This variation impacts Section 6.3 of the KEYTRUDA SPC, as well as the information for healthcare professionals in the leaflet.</p>

    <p style="font-size: 10pt;"><strong>Priority level:</strong> Standard</p>

    <p style="font-size: 10pt;">Please note that, due to the approval of procedures II/0160 + II/0161 + II/0162 in the same time frame, only consolidated PI’s with the changes from all three procedures are available in MUSE - <a href="">muse.merck.com">muse.merck.com</.../p>

    <p style="font-size: 10pt;">Therefore, we attach the English WRM and CRT PI with the changes of II/0162 only to this mail.</p>

    <p style="font-size: 10pt;">Thank you and warm regards,</p>

    <p style="font-size: 10pt;">Natalia</p>

    January 30, 2025

    Hi[mention:a5732d26eb3840a7b63ef0bcb4455329:e9ed411860ed4f2ba0265705b8793d05] 

    Try this it may help you.

    <p style="font-size: 10pt;">Dear colleagues,</p>
    <p style="font-size: 10pt;">
    Please note that the EU approval by CHMP Positive opinion has been granted on
    05 December 2024 for<br />KEYTRUDA (pembrolizumab) for variation
    EMEA/H/C/3820/II/016, which removes the instruction "Remove from light" for
    the diluted product from the Product Information.
    </p>
    <p style="font-size: 10pt;">
    There is no corresponding CCDS update for this update; however, the correction
    is linked to CCDS-MK3475-IV-042024.
    </p>
    <p style="font-size: 10pt;">
    This variation impacts Section 6.3 of the KEYTRUDA SPC, as well as the
    information for healthcare professionals in the leaflet.
    </p>
    <p style="font-size: 10pt;">Priority level: Standard</p>
    <p style="font-size: 10pt;">
    Please note that, due to the approval of procedures II/0160 + II/0161 +
    II/0162 in the same time frame, only consolidated PI&rsquo;s with the changes
    from all three procedures are available in MUSE -
    muse.merck.com"&gt;muse.merck.com
    </p>
    <p style="font-size: 10pt;">
    Therefore, we attach the English WRM and CRT PI with the changes of II/0162
    only to this mail.
    </p>
    <p style="font-size: 10pt;">Thank you and warm regards,</p>
    <p style="font-size: 10pt;">Natalia</p>

    davidj137213
    January 30, 2025

    Why don't you try using HTML tables (or <p> as other user suggested)  instead of <span>? I think it's much easier 

    mikes0011
    Brainy
    January 30, 2025

    The prior examples offered here by other users demonstrate some nice clean HTML.  I think the main takeaway is, you should probably stick to hand-entered basic HTML for emails instead of pasting in whatever junk gets auto-generated elsewhere (it looks like your original version was generated by Word or something, with lots of overhead and fluff and unnecessary junk included).  The basics necessary for a simple HTML email are pretty easy.

    mathieud0001
    January 30, 2025

    Already answered this question here:

     https://community.appian.com/discussions/f/general/38389/some-parts-of-the-html-text-are-getting-removed 

    Maybe ask Chat GPT to clean up your html?